S360-0122 Screening compound: 4-(5-{3-[(4-fluorophenyl)methyl]-1,2,4-oxadiazol-5-yl}-1,2,4-oxadiazol-3-yl)pyridine

S360-0122 Screening compound: 4-(5-{3-[(4-fluorophenyl)methyl]-1,2,4-oxadiazol-5-yl}-1,2,4-oxadiazol-3-yl)pyridine
S360-0122 Screening compound: 4-(5-{3-[(4-fluorophenyl)methyl]-1,2,4-oxadiazol-5-yl}-1,2,4-oxadiazol-3-yl)pyridine alternative view

Chemical Structure Depiction of ChemDiv screening compound S360-0122
4-(5-{3-[(4-fluorophenyl)methyl]-1,2,4-oxadiazol-5-yl}-1,2,4-oxadiazol-3-yl)pyridine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S360-0122

Molecular Formula

C16H10FN5O2 (C16 H10 FN5 O2)

Compound Name

4-(5-{3-[(4-fluorophenyl)methyl]-1,2,4-oxadiazol-5-yl}-1,2,4-oxadiazol-3-yl)pyridine

IUPAC name

4-(5-{3-[(4-fluorophenyl)methyl]-124-oxadiazol-5-yl}-124-oxadiazol-3-yl)pyridine

SMILES

Fc1ccc(Cc2noc(-c3nc(-c4ccncc4)no3)n2)cc1

InChI

InChI=1S/C16H10FN5O2/c17-12-3-1-10(2-4-12)9-13-19-15(23-21-13)16-20-14(22-24-16)11-5-7-18-8-6-11/h1-8H,9H2

InChI Key

RSTLIUJFAXDMFP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29007055

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

323.29

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.944

Distribution Coefficient, logD

2.944

Water Solubility, LogSw

-2.85

Polar Surface Area

73.740

Acid Dissociation Constant (pKa)

30.13

Base Dissociation Constant (pKb)

3.68

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

6.30

S360-0122 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • Epigenetic

References: we are preparing a list of scientific research reports with S360-0122 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S360-0122?
Check Price and Availability of S360-0122, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S360-0122 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S360-0122
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S360-0122
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S360-0122 available by request